In vivo efficacy studies of a candidate alzheimer treatment in a transgenic mouse model
Ended Purchase Order Awarded Last action
- Contract number
- 75N95021P00466
- Awardee
-
QPS Austria GMBH UEI V615KLQ23YA5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $199,812
Award facts
- Opportunity
-
- In vivo efficacy studies of a candidate Alzheimer treatment in a transgenic mouse model Pre-Solicitation · 75N95021Q00269 · Posted Jun 29, 2021
- In vivo efficacy studies of a candidate Alzheimer treatment in a transgenic mouse model Solicitation · Posted Aug 3, 2021
- Contract value 100% obligated
- $199,812.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute on Aging National Institutes of Health, Department of Health and Human Services
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Austria
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $8,721 | |
| Supplemental Agreement for work within scope | $4,893 | |
| Original award | $186,198 |
About this award
This is a $199,812 firm fixed price purchase order awarded by the National Institutes of Health's (NIH) National Institute on Aging (NIA) to QPS Austria GMBH, a contract research organization. The contract is for in vivo efficacy studies of a candidate Alzheimer's treatment in a transgenic mouse model. This award is part of the NIA's Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study, which aims to identify FDA-approved drugs that may be repurposed as disease-modifying Alzheimer's treatments. The award has a period of performance from September 30, 2021 to September 29, 2022. There is no set aside designation on this contract.
Quick answers
Who was awarded contract 75N95021P00466?
75N95021P00466 was awarded to QPS Austria GMBH by National Institute on Drug Abuse (National Institutes of Health) on September 30, 2021.
How much is contract 75N95021P00466 worth?
The government has obligated $199,812 on 75N95021P00466.
Which agency awarded contract 75N95021P00466?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021P00466, with funding from National Institute on Aging (National Institutes of Health).
Was contract 75N95021P00466 competed?
The extent of competition for 75N95021P00466 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award